x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

health & fitness medicine

All Episodes

18:49

Treating Alcohol Use Disorder

Psychopharmacology and Psychiatry Updates ·

2022/06/26

Which medications can we offer for alcohol use disorder? This episode will offer practical tips for selecting and initiating medications for managing patients with at-risk drinking and alcohol use disorder. Guest: Joji Suzuki, M.D. Interviewer: Wegdan Rashad, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 0.5 CMEs: What Clinicians Need to KnowAbout Alcohol Use Disorder -Interview with Joji Suzuki, M.D.

en

12:21

Topiramate and Stimulant Replacement Therapy for...

Psychopharmacology and Psychiatry Updates ·

2022/06/21

This episode discusses the evidence and benefits of topiramate and stimulant replacement therapy for cocaine use disorder. It also addresses the use of these medications when there are comorbidities, such as alcohol use disorder and ADHD. Faculty: Andrew Saxon, M.D. Hosts: Jessica Diaz, M.D. Learn more about our memberships here Earn 1 CME: Experimental Pharmacotherapies for Stimulant Use Disorder Topiramate and Methylphenidate for Cocaine Use Disorder and Its Comorbidities

en

09:07

Association Between Mood Disorders and COVID-19

Psychopharmacology and Psychiatry Updates ·

2022/06/16

In this episode, we discuss the problem of pre-existing mood disorders increasing the risk of hospitalization and death among people infected with COVID-19. Why does this occur? Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 34 Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death

en

11:07

Antidepressants and Naltrexone for Stimulant Use...

Psychopharmacology and Psychiatry Updates ·

2022/06/11

This episode discusses the evidence of mirtazapine, bupropion, and naltrexone for stimulant use disorder. Are these promising treatments? Are they really effective? Faculty: Andrew Saxon, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 1 CME: Experimental Pharmacotherapies for Stimulant Use Disorder Antidepressants and Naltrexone for Methamphetamine Use Disorder

en

10:37

CANMAT Task Force Recommendations for the Use of...

Psychopharmacology and Psychiatry Updates ·

2022/06/06

Can we use ketamine as a maintenance treatment for MDD? In this episode, Dr. Phelps discusses CANMAT’s recommendations for the use of ketamine for MDD. Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 35 The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults With Major Depressive Disorder

en

10:13

Stimulant Replacement Therapies for Methamphetamine...

Psychopharmacology and Psychiatry Updates ·

2022/06/01

Can methylphenidate help amphetamine and methamphetamine use disorder? This episode discusses stimulant replacement therapies for methamphetamine and amphetamine use disorder. This includes the possible use of MPH in patients with underlying ADHD. Faculty: Andrew Saxon, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 1 CME: Experimental Pharmacotherapies for Stimulant Use Disorder Stimulant Replacement Therapies for Methamphetamine and Amphetamine Use Disorder

en

19:04

Premenstrual Mood Syndromes

Psychopharmacology and Psychiatry Updates ·

2022/05/27

What is the first-line treatment for premenstrual mood syndromes? In this episode, Dr. Lauren Osborne discusses premenstrual mood syndromes and offers valuable insights regarding their management. She also discusses novel medications, such as brexanolone and drospirenone. Guest: Lauren Osborne, M.D. Interviewer: Wegdan Rashad, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 0.5 CMEs: Premenstrual Mood Syndromes -Interview with Lauren Osborne, M.D.

en

10:28

Stimulant Use Disorder: Diagnosis and Assessment

Psychopharmacology and Psychiatry Updates ·

2022/05/22

This episode discusses the course and prognosis for stimulant use disorder as well as how to diagnose and assess this disorder. It also explains the loss of control over stimulant use, dysfunctional behaviors, co-occurring psychiatric disorders, and medical side effects. Faculty: Andrew Saxon, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 1 CME: Experimental Pharmacotherapies for Stimulant Use Disorder Stimulants Use: Course, Assessment, and Diagnosis

en

09:23

Zuranolone for Postpartum Depression

Psychopharmacology and Psychiatry Updates ·

2022/05/17

Should zuranolone be a first-line treatment for postpartum depression? In this episode, Dr. Phelps discusses a randomized trial of zuranolone—a new neuromodulatory steroid—in the context of previous guidelines for the treatment of postpartum depression. Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 35 Effect of Zuranolone vs Placebo in Postpartum Depression

en

08:54

Long-Term Treatment of First Episode of Psychosis

Psychopharmacology and Psychiatry Updates ·

2022/05/12

How long should we continue antipsychotic treatment in FEP? This episode discusses the long-term treatment of FEP, including the duration of antipsychotic treatment and the effects of dose reduction, the pros and cons of antipsychotic treatment, and the importance of collaborative treatment. Faculty: Stephen Marder, M.D. Host: Jessica Diaz, M.D. Learn more about our memberships here Earn 0.75 CMEs: Assessment and Management of First Episode of Psychosis Long-Term Treatment of FEP

en

09:11

The Effects of Antipsychotic Treatment on the Brain...

Psychopharmacology and Psychiatry Updates ·

2022/05/07

In this episode, Dr. Phelps discusses the recent literature on brain volume changes after first-episode psychosis. What causes brain volume reductions—the illness or antipsychotics? Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 34 The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies

en

09:43

Health Issues in First Episode of Psychosis

Psychopharmacology and Psychiatry Updates ·

2022/05/02

Do people with schizophrenia already have a high risk of metabolic effects early in the course of illness? This episode discusses health concerns for first-episode patients, including life expectancy, metabolic conditions in drug-naïve patients, the signs of developing insulin resistance, and the approaches for early metabolic changes. Faculty: Stephen Marder, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Assessment and Management of

en

08:34

Psychopharmacology for Treatment-Resistant Early...

Psychopharmacology and Psychiatry Updates ·

2022/04/27

This episode discusses treatment-resistant early psychosis, including treatment with LAIs and the use of clozapine for treatment-resistant cases. Faculty: Stephen Marder, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Assessment and Management of First Episode of Psychosis Psychopharmacology for People With Treatment-Resistant Early Psychosis

en

19:26

Assessing and Treating Adult ADHD

Psychopharmacology and Psychiatry Updates ·

2022/04/22

Does adult-onset ADHD really exist? This episode discusses the neurobiological underpinnings of adult ADHD. It also describes how to assess adults with ADHD, important considerations, and some management strategies. Guest: Oscar Bukstein, M.D. Interviewer: Mohan Gautam, D.O. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: The Clinical Guide to Adult ADHD -Interview with Oscar Bukstein, M.D., M.P.H.

en

12:02

Medications for Binge Eating Disorder

Psychopharmacology and Psychiatry Updates ·

2022/04/17

Is binge eating an addictive disorder or an impulse-control disorder? In this episode, Dr. Phelps summarizes the evidence of efficacy of several medications for binge eating disorder. He also discusses the psychopathology and neuropharmacology of binge eating disorder. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 33 Prospects for New Drugs To Treat Binge Eating Disorder: Insights From

en

09:03

Antipsychotics for First Episodes of Psychosis

Psychopharmacology and Psychiatry Updates ·

2022/04/12

This episode discusses considerations when treating first-episode psychosis with antipsychotics, treatment principles and response, and early predictors of poor long-term course. Faculty: Stephen Marder, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Assessment and Management of First Episode of Psychosis Management of First Episodes: Antipsychotics

en

09:37

Effects on Suicidal Risk With Different Medications

Psychopharmacology and Psychiatry Updates ·

2022/04/07

This episode discusses whether clozapine and other medications can reduce the risk of suicide. Is it a "class effect" of antipsychotics, or is it specific to clozapine? Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 33 Effects on Suicidal Risk: Comparison of Clozapine to Other Newer Medicines Indicated to Treat Schizophrenia or Bipolar Disorder

en

10:22

Risks of Using Cannabinoids

Psychopharmacology and Psychiatry Updates ·

2022/04/02

What are the risks associated with cannabinoid use? This episode discusses some risks, such as overdose, increased ER visits, and cardiovascular risks as well as the effects on pulmonary health. Faculty: Diana Martinez, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment Cannabinoids and Risks for Patients

en

19:37

Lithium: How to Manage Dosage

Psychopharmacology and Psychiatry Updates ·

2022/03/28

How do you titrate lithium doses? In this episode, Dr. David Osser discusses practical insights on lithium dosing and monitoring strategies. Guest: David Osser, M.D. Interviewer: Mohan Gautam, D.O. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Lithium: How to Manage Dosage andSide Effects and Persuade Patients toTake It - Interview with David Osser, M.D.

en

07:58

CBD as a Medication

Psychopharmacology and Psychiatry Updates ·

2022/03/23

Can we use CBD for psychiatric disorders? This episode discusses the evidence for medical uses of CBD for various disorders, such as childhood epilepsy, schizophrenia, social anxiety disorder, opioid use disorder, and cannabis use disorder. Faculty: Diana Martinez, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment

en

426 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown